In a study with a mouse model of PD treated with dopaminergic toxin MPTP, the administration of HDAC inhibitor phenyl butyrate significantly reduced the diminution of dopamine and loss of tyrosine hydroxylase-positive neurons in the substantia nigra (Gardian et al., 2004). This evidence concerns the gene HDAC9 and Parkinson disease.